Fluticasone furoate + Umeclidinium + Vilanterol (Trelegy Ellipta) is indicated for maintenance treatment to prevent and relieve symptoms associated with chronic obstructive pulmonary disease (COPD).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
